✦ LIBER ✦

Effects of caerulein-related peptides on cholecystokinin receptor bindings in brain and pancreas

✍ Scribed by Masafumi Fujimoto; Ken'ichi Igano; Kunio Watanabe; Itsuko Irie; Ken Inouye; Tadashi Okabayashi

Book ID: 115778503
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 425 KB
Volume: 34
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(85)90616-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholecystokinin peptides and receptor bi

Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment

✍ C Löfberg; J Harro; V Matto; L Oreland 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Cholecystokinin receptor binding in brai

Cholecystokinin receptor binding in brain and pancreas: Regulation of pancreatic bindign by cyclic and acyclic guanine nucleotides

✍ Roberts B. Innis; Solomon H. Snyder 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Comparative effect of chronic bombesin,

Comparative effect of chronic bombesin, gastrin-releasing peptide and caerulein on the rat pancreas

✍ Christiane Damgé; Amor Hajri; Evelyne Lhoste; Marc Aprahamian 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 882 KB

Gallbladder motility in sheep: effects o

Gallbladder motility in sheep: effects of cholecystokinin and related peptides

✍ Y. RUCKEBUSCH; G. SOLDANI 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

Effects of cholecystokinin-related pepti

Effects of cholecystokinin-related peptides on self-stimulation behaviour in rats

✍ Mária Balázs; Helmut Schwarzberg; Botond Penke; Gyula Telegdy 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Effect of cholecystokinin analogue caeru

Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat

✍ Cosimo Sperti; Carmelo Militello; Roubik Behboo; Edwin Khajeturian; Sergio Pedra 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

The effects of the cholecystokinin (CCK)-analogue, caerulein, and CCKreceptor antagonist lorglumide (CR-1409) on pancreatic carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) were studied. One hundred thirty rats were divided into the following 10 treatment groups: group 1, DMBA (2-3 mg